However, no deletions of TP53 were recognized in 16 MM patients either at presentation or during follow-up, proposing that TP53 deletions are not a universal event in the development of MM but rather limited to a subclass of patients with poor prognosis [491]. The gene discussed is TP53; the disease is Miyoshi myopathy.